TSX-V: CANB
Equipped with a refreshed strategy, new
products and new provincial markets, the future for Stigma Grow is
strong.
CALGARY, AB, Jan. 29, 2021 /CNW/ - CanadaBis Capital Inc.
("CanadaBis" or "the Company") is pleased to announce that its 100%
owned subsidiary, 1998643 AB LTD. ("Stigma Grow") is now selling
their expanding lineup of first-to-market hydrocarbon cannabis
concentrates across British Columbia.
"We are excited to finally bring our powerful lineup of
live-resin concentrates to a province who has long awaited the type
of quality, potency and pricing they are used to getting from the
legacy market," said Travis
McIntyre, CEO of CanadaBis Capital Inc. "For the past few
months, we have been revisiting our product categories and pricing
models to cater to those consumers who are still looking for more
out of LP offerings. We are looking to leverage our relationships
and in-house expertise to lead the growth of the concentrates
category across Canada – ensuring
our brands remain engaging and educational, while our products
continue to lead the industry in quality and fair pricing."
Equipped with their cannabis 2.0 direct sales license since
December 2020, and with product
listings currently across Alberta,
BC, Manitoba and Saskatchewan, Stigma Grow is looking to the
relaunch of all their products under their own brand name as a
chance to introduce new brands, adjust pricing and make the biggest
impact possible.
Starting in February of 2021, Stigma Grow will be introducing
Dab Bods; a low-cost, high-value hydrocarbon concentrate offering
that will bring the lowest price shatter, sugar and more to
provinces currently struggling with the high price of existing
offerings.
"Dab Bods will be an approachable brand that seeks to introduce
concentrates to those who do not have a lot to spend, but who see
the value and lifestyle benefits that come from switching over to a
more discreet, efficient and effective cannabis product," says
Chad Hason, VP of Sales and
Marketing for Stigma Grow.
As well, Stigma Grow will be the first-to-market for RSO
capsules; a popular and vary potent ingestible popular with
high-tolerance consumers and within the medical market. This
full-spectrum hydrocarbon capsule comes in various strengths and
represents one of the only capsules on the market offering the
synergistic benefits of the entourage effect.
Finally, Stigma Grow is reducing the price of their instantly
popular, live-resin, HTFSE vape cartridges to compete against the
lower costs of a variety of vape cartridge distillates.
"While we work with our valued communities to explain the
differences and superior nature of a true live-resin vape offering
versus a distillate", explains Chad, "our goal is to present our
audiences with the ideal mix of engaging messages, superior product
and incredible pricing. Once price or understanding is no longer a
barrier to recognizing higher quality, we believe the experiences
consumers have will lead to the brand loyalty we seek."
In addition to this the Company has entered into an agreement
with an arms-length party who has opted to increase their share
hold position within CanadaBis Capital via shares for
debt.
This arrangement, in connection with the Services, the Company
has agreed to issue to the (the "Creditor") an aggregate of 558,590
Common Shares in the capital of the Company (the "Debt Shares") at
a deemed issue price of $0.10 per
Debt Share (the "Debt Settlement"). The issuance of the Debt
Shares is subject to the TSX Venture Exchange's final
approval. All Debt Shares issued in connection with the Debt
Settlement are subject to a statutory hold period of four months
plus a day from the issuance of the Debt Shares in accordance with
applicable securities legislation.
About Stigma Grow
Stigma Grow is a cutting-edge cannabis cultivation and
extraction
company positioned advantageously to meet the unmet market demands and stigmas within
the legal cannabis industry head on, with products designed to disturb the status
quo and dramatically shift the conversation surrounding
Canada's legal
cannabis industry.
About CanadaBis Capital Inc.
CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated
Canadian cannabis company focused on achieving large-scale
growth in the fast-emerging
global cannabis market. By targeting organic growth opportunities alongside the right-fit
partners, we remain focused on finding and capitalizing on chances to grow,
diversify and continue to lead our industry.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
INFORMATION:
This news release includes certain
"forward-looking statements" under applicable Canadian securities
legislation. Forward-looking statements include, but are not
limited to statements with respect to our business and operations;
timing of the Company's profitability; the demand and sales volumes
of the Company's products, and our general business plans.
Forward-looking statements are necessarily based upon a number of
assumptions including: the ability of the Company's products to
compete with the pricing and product availability on the
black-market; the market demand for the Company's products; and
assumptions concerning the Company's competitive advantages. These
assumptions, while considered reasonable, are subject to known and
unknown risks, uncertainties, and other factors which may cause
actual results and future events to differ materially from those
expressed or implied by such forward-looking statements. Such
factors include, but are not limited to: compliance with extensive
government regulation, the general business, economic, competitive,
political and social uncertainties; ability to sustain or create a
demand for a product; requirement for further capital; delay or
failure to receive board, shareholder or regulatory approvals; the
results of operations and such other matters as set out in the
Company's continuous disclosure on SEDAR at www.sedar.com.
There can be n no assurance that such statements will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on
forward-looking statements. Investors are cautioned that
forward-looking information is not based on historical facts but
instead reflects management's expectations, estimates or
projections concerning future results or events based on the
opinions, assumptions and estimates of management considered
reasonable at the date the statements are made. Although we believe
that the expectations reflected in such forward-looking information
are reasonable, such information involves risks and uncertainties,
and undue reliance should not be placed on such information, as
unknown or unpredictable factors could have a material adverse
effect on our future results, performance or achievements.
Should one or more of these risks or uncertainties materialize,
or should assumptions underlying the forward-looking information
prove incorrect, actual results may vary materially from those
described herein as intended, planned, anticipated, believed,
estimated or expected. Although the Company has attempted to
identify important risks, uncertainties and factors which could
cause actual results to differ materially, there may be others that
cause results not to be as anticipated, estimated or intended. The
Company does not intend, and does not assume any obligation, to
update this forward-looking information except as otherwise
required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE CanadaBis Capital Inc.